https://orcid.org/0000-0002-0206-277X
About the Authors
- Caroline I. Larkin
-
Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliations Joint Carnegie Mellon University - University of Pittsburgh PhD Program in Computational Biology, Pittsburgh, Pennsylvania, United States of America, Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Matthew D. Dunn
-
Roles Investigation, Writing – original draft
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Jason E. Shoemaker
-
Roles Conceptualization, Funding acquisition, Writing – review & editing
Affiliations Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- William B. Klimstra
-
Roles Conceptualization, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing
Affiliations Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- James R. Faeder
-
Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: faeder@pitt.edu
Affiliation Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
Competing Interests
The authors of this manuscript have the following competing interests. W.B.K. is a co-founder of Advanced Virology. The Klimstra laboratory has received unrelated funding in support of sponsored research agreements from SAB Biotherapeutics. The remaining authors have declared no competing interest.